Neurocysticercosis(NCC) is the commonest parasitic infection of the central nervous system. It is the commonest cause of focal seizures in India. It can also present with headaches, movement disorders, stroke, cognitive decline and multitude of complications depending on its location. Parenchymal NCC is more common than extraparenchymal NCC. There is considerable variation in the treatment practices including administration of anti-helminthic agents and corticosteroids. Extra-parenchymal NCC is rare and can occur in the subarachnoid space or intraventricularly. Extra-parenchymal NCC is managed surgically in several instances. There is scant literature on the long term follow up of this condition. This registry will enable collection of data on the clinical, laboratory and imaging features, treatment trends and long term outcomes of both parenchymal and extra-parenchymal neurocysticercosis.
Age range
14 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Clinical features in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 6 months
Laboratory features
Timeframe: 6 months
Imaging features
Timeframe: 6 months
Treatment trends in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 6 months
Treatment trends in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 1 year
Treatment trends in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 3 years
Treatment trends in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 5 years
Outcomes in patients with parenchymal and extraparenchymal neurocysticercosis - 6 months
Timeframe: 6 months
Outcomes in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 1 year
Outcomes in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 3 years
Outcomes in patients with parenchymal and extraparenchymal neurocysticercosis
Timeframe: 5 years
Extra-parenchymal neurocysticercosis
Timeframe: 6 months